Stay updated on CD19/22 CAR T Cells in DLBCL Clinical Trial
Sign up to get notified when there's something new on the CD19/22 CAR T Cells in DLBCL Clinical Trial page.

Latest updates to the CD19/22 CAR T Cells in DLBCL Clinical Trial page
- Check3 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2, indicating a minor revision; the 'Back to Top' link was removed. Overall, changes are limited to the version bump and a small navigation change.SummaryDifference0.1%
- Check10 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.1%
- Check18 days agoChange DetectedThe web page has updated its facility name and location details, specifically emphasizing St. Louis, Missouri, and has introduced new medical terminology related to diffuse large B-cell lymphoma. Additionally, the revision number has been updated to v3.0.0.SummaryDifference2%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.0%
- Check39 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.0%
- Check46 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.7%
Stay in the know with updates to CD19/22 CAR T Cells in DLBCL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CD19/22 CAR T Cells in DLBCL Clinical Trial page.